Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.
about
The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic responseTetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin TetramerTransthyretin regulates the migration and invasion of JEG-3 cells.Serum Protein Profile in Women With Pregnancy Morbidity Associated With Antiphospholipid Syndrome.Interleukin-10: a pleiotropic regulator in pregnancy.Serum markers of pre-eclampsia identified on proteomics.Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary?Neutrophil migration into the placenta: Good, bad or deadly?Understanding Pre-Eclampsia Using Alzheimer's Etiology: An Intriguing Viewpoint.Peptidome Analysis of Human Serum From Normal and Preeclamptic Pregnancies.Preeclampsia and health risks later in life: an immunological link.Targeting STOX1 in the therapy of preeclampsia.Hypertensive disorders in pregnancy and later dementia: a Swedish National Register Study.Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsiaAmyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines.MicroRNA regulation of Transthyretin in trophoblast differentiation and Intra-Uterine Growth Restriction.Urinary excretion of C5b-9 is associated with the anti-angiogenic state in severe preeclampsia.Molecular Mechanisms of Preeclampsia.The Physiological Roles of Amyloid-β Peptide Hint at New Ways to Treat Alzheimer's Disease.
P2860
Q28547541-9EDF47D3-7728-452B-B56A-C7F4FA8B846BQ28551432-07ABA73F-0B9E-4EDD-BA7A-7CEA37D3F36FQ33598128-FE247B4E-44E7-49C7-BF04-9139A4E62108Q33604935-9804D2B0-2E34-4A76-A993-D17ACE04DF7DQ35243821-6252D4A6-B12A-42CC-A019-AE622783EF95Q36045933-2B27CB02-CAAF-4217-B610-ED7E96DD5641Q36357099-87E1A3E7-C57B-4484-A307-3FEF940420F1Q36857949-3E99B5AC-AEC0-4F3B-8611-539CFAC09C61Q38638997-4AA7FB41-F961-4810-ACEB-523DCB82A74CQ38692328-11C1C5A7-03EE-42BF-A221-EB51E9B5530DQ38849036-BC34429C-04D0-43A9-AC19-565487ABC184Q38991116-E10A4C97-9CF1-4D26-B764-174EA1128E0DQ39017068-9A5858B1-A17D-4EA8-A01B-23A2B599EE90Q41158848-9B5BE8E7-4649-4D5B-878C-62CDE86C2A9DQ46502103-2FC3F7D4-816C-4BEB-9723-86A5F12343A5Q47108034-F90020B8-8427-423A-BE3F-B2663A47EAA3Q54301416-D4EA6D17-3BF9-49DB-A64F-6E1F81600E22Q54901493-8A453BE0-5A33-4759-85EB-CA45604B2BD7Q55411317-11C73E91-370A-43A7-B6C3-FB3335AE6590
P2860
Transthyretin is dysregulated in preeclampsia, and its native form prevents the onset of disease in a preclinical mouse model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Transthyretin is dysregulated ...... in a preclinical mouse model.
@ast
Transthyretin is dysregulated ...... in a preclinical mouse model.
@en
Transthyretin is dysregulated ...... in a preclinical mouse model.
@nl
type
label
Transthyretin is dysregulated ...... in a preclinical mouse model.
@ast
Transthyretin is dysregulated ...... in a preclinical mouse model.
@en
Transthyretin is dysregulated ...... in a preclinical mouse model.
@nl
prefLabel
Transthyretin is dysregulated ...... in a preclinical mouse model.
@ast
Transthyretin is dysregulated ...... in a preclinical mouse model.
@en
Transthyretin is dysregulated ...... in a preclinical mouse model.
@nl
P2093
P2860
P1476
Transthyretin is dysregulated ...... in a preclinical mouse model.
@en
P2093
Aftab Ahmed
Anders Olofsson
Dang Vu Hoang
Goran Berg
James Padbury
Satyan S Kalkunte
Shi-Bin Cheng
Stefan Neubeck
Surendra Sharma
Udo R Markert
P2860
P304
P356
10.1016/J.AJPATH.2013.07.022
P407
P577
2013-09-10T00:00:00Z